Preclinical studies have identified GLP-1 receptors throughout the gastrointestinal tract, including on enteroendocrine cells, neurons, and immune cells
MOUNJARO (tirzepatide) 10mg KwikPen delivers the first approved dual GIP and GLP-1 receptor agonist as a 10mg/0.6ml dose per injection, indicated for use in adults and, per the current U.S
Personalized Treatment Plan Tailored dosage: We believe in a personalized approach
Without treatment, it can lead to seizures, coma, and even death
This is because your body stores carbohydrates as glycogen, which is bound to water
We believe in providing continuous support through routine check-ins with our dedicated care team